XATRAL XL TABLET 10 mg

Therapeutic indications

Treatment of the functional symptoms of benign prostatic hypertrophy (BPH). Adjuvant treatment to a catheter in first episode of acute urinary retention (AUR) related to benign prostatic hypertrophy (BPH).

Contraindications

This medicine must not be administered in the following situations:

• hypersensitivity to alfuzosin and/or any of the other ingredients;
• postural hypotension,
• liver failure;
• severe kidney failure (creatinine clearance <30 ml/min),
• in combination with ritonavir
• Concomitant administration with potent CYP3A4 inhibitors

Posology and method of administration

Benign Prostatic Hypertrophy (BPH):

The recommended dosage is one 10-mg tablet per day, to be taken immediately after the evening meal.

Adjuvant treatment to a catheter in the first episode of acute urinary retention related to benign prostatic hypertrophy:

The recommended dosage is one 10-mg tablet per day, to be taken after a meal, from the first day of catheterization onwards.

The treatment is administered for 3 to 4 days, i.e. 2 to 3 days while the catheter is in place and 1 day after it is removed.

The tablet must be swallowed whole with a glass of water (see Special warnings and special precautions for use – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).